599 filings
Page 9 of 30
6-K
s0jyad57dq
9 Nov 17
Report of Foreign Issuer
12:00am
6-K
3wwk ivtkdu8
9 Nov 17
Report of Foreign Issuer
12:00am
6-K
nnm4jebhz46v19ee
25 Aug 17
Consolidated Interim Financial Statements
12:00am
6-K
wxq0bqlqzpi1
12 Jul 17
Portage Announces Results of Shareholders Meeting and Provides Update on Its Portfolio Companies
12:00am
6-K
h2oxnt7tm 5srtympyx5
17 May 17
Biohaven Announces Closing of Initial Public Offering and Full Exercise of Underwriters? Option to Purchase Additional Shares
12:00am
6-K
2m7m8c lcojdnci64j
10 May 17
Portage?s Holding In Biohaven
12:00am
6-K
ojf1rmj8mhho6sd8
8 May 17
Biohaven Announces Pricing of Its Initial Public Offering of Common Shares
12:00am
3
u170n7mkux3x
3 May 17
Initial statement of insider ownership
12:00am
6-K
kyl69
12 Apr 17
Portage Provides Update on Its Portfolio Companies
12:00am
6-K
jsdz bb2px0
10 Apr 17
Biohaven Files Registration Statement for Proposed Public Offering of Its Common Shares
12:00am
S-8
k1e3zw b3c8nbtxp
20 Mar 17
Registration of securities for employees
12:00am
6-K
6enkzf4oiqpxh2ls6
14 Mar 17
Biohaven Closes Second Tranche of Private Placement and Appoints Two New Directors to Board
12:00am
6-K
zfb cm20ggxtr
27 Feb 17
Consolidated Interim Financial Statements
12:00am
6-K
j1ygu833wb edlgee
9 Dec 16
Biohaven? BHV-0223 Is Granted Orphan Drug Designation In the Treatment of Amyotrophic Lateral Sclerosis
12:00am
6-K
p9xpv2owlln12 oy85h
30 Nov 16
Portage Announces Spin-out of Eygen Limited
12:00am
6-K
18bngxr28goe
28 Nov 16
Interim Financials for the Three and Six Months Ended September 30, 2016
12:00am
6-K
j4m3ay s8l8rnjor3i
3 Nov 16
Biohaven Raises $80 Million
12:00am
6-K
bal4bh8
21 Sep 16
Chairman's Letter to Shareholders
12:00am
6-K
8jh gdjg1jy2
30 Aug 16
Consolidated Interim Financials for the Three Months Ended June 30, 2016 and Management Discussion and Analysis for the Same Period
12:00am